Unknown
Who we are
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
Phase 2 Study of DKN-01 in Colorectal Cancer
QUILT 3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
Assessing the Immunogenicity of pING-hHER3FL
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Participants With Resected Solid Tumors and in Combination With Pembrolizumab in Participants With Unresectable Solid Tumors
